FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Manfred Johannsen

Research Profile

Disorders

Procedures

Occupations

Magnetics

Concepts & Ideas

Chemicals & Drugs

Biological Tumor Markers

Objects

Physiology

Gene Expression Regulation, Neoplastic

Living Beings

Rats

Co-author Network

Publications

TOP 3
Jonas Busch; Viktor Grünwald; Stefan Hinz; Manfred Johannsen; Carsten Kempkensteffen; Ahmed Magheli; Kurt Miller; Christoph Seidel; Ingmar Wolff; Steffen Weikert
Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors.
Gareth Catchpole; Alexander Platzer; Cornelia Weikert; Carsten Kempkensteffen; Manfred Johannsen; Hans Krause; Klaus Jung; Kurt Miller; Lothar Willmitzer; Joachim Selbig; Steffen Weikert
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
Manfred Johannsen; Gianluca Spitaleri; Giuseppe Curigliano; Jan Roigas; Steffen Weikert; Carsten Kempkensteffen; Andreas Roemer; Christian Kloeters; Patrik Rogalla; Gabriele Pecher; Kurt Miller; Alexander Berndt; Hartwig Kosmehl; Eveline Trachsel; Manuela Kaspar; Valeria Lovato; Reinerio González-Iglesias; Leonardo Giovannoni; Hans D Menssen; Dario Neri; Filippo de Braud
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Manfred Johannsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jonas Busch; Viktor Grünwald; Stefan Hinz; Manfred Johannsen; Carsten Kempkensteffen; Ahmed Magheli; Kurt Miller; Christoph Seidel; Ingmar Wolff; Steffen Weikert
Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors.
European urology 2011;60(6):1163-70.
2011: Gareth Catchpole; Alexander Platzer; Cornelia Weikert; Carsten Kempkensteffen; Manfred Johannsen; Hans Krause; Klaus Jung; Kurt Miller; Lothar Willmitzer; Joachim Selbig; Steffen Weikert
Metabolic profiling reveals key metabolic features of renal cell carcinoma.
Journal of cellular and molecular medicine 2011;15(1):109-18.
2010: Manfred Johannsen; Gianluca Spitaleri; Giuseppe Curigliano; Jan Roigas; Steffen Weikert; Carsten Kempkensteffen; Andreas Roemer; Christian Kloeters; Patrik Rogalla; Gabriele Pecher; Kurt Miller; Alexander Berndt; Hartwig Kosmehl; Eveline Trachsel; Manuela Kaspar; Valeria Lovato; Reinerio González-Iglesias; Leonardo Giovannoni; Hans D Menssen; Dario Neri; Filippo de Braud
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2010;46(16):2926-35.
2010: Manfred Johannsen; Burghard Thiesen; Peter Wust; Andreas Jordan
Magnetic nanoparticle hyperthermia for prostate cancer.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2010;26(8):790-5.
2009: Andreas H Wille; Manfred Johannsen; Kurt Miller; Serdar Deger
Laparoscopic partial nephrectomy using FloSeal for hemostasis: technique and experiences in 102 patients.
Surgical innovation 2009;16(4):306-12.
2009: Monika Jung; Hans-Joachim Mollenkopf; Christina Grimm; Ina Wagner; Marco Albrecht; Tobias Waller; Christian Pilarsky; Manfred Johannsen; Carsten Stephan; Hans Lehrach; Wilfried Nietfeld; Thomas Rudel; Klaus Jung; Glen Kristiansen
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
Journal of cellular and molecular medicine 2009;13(9B):3918-28.
2009: Manfred Johannsen; Anne Flörcken; Axel Bex; Jan Roigas; Marco Cosentino; Vincenzo Ficarra; Christian Kloeters; Matthias Rief; Patrik Rogalla; Kurt Miller; Viktor Grünwald
Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
European urology 2009;55(6):1430-8.
2009: Angelika Tölle; Monika Jung; Michael Lein; Manfred Johannsen; Kurt Miller; Holger Moch; Klaus Jung; Glen Kristiansen
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
BMC cancer 2009;9():248.
2009: Carsten Kempkensteffen; Stefan Hinz; Manfred Johannsen; Hans Krause; Ahmed Magheli; Frank Christoph; Jens Köllermann; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression of Mcl-1 splicing variants in clear-cell renal cancer and their correlation with histopathological parameters and prognosis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(2):73-9.
2008: Azizbek Ramankulov; Michael Lein; Manfred Johannsen; Mark Schrader; Kurt Miller; Stefan A Loening; Klaus Jung
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
Cancer letters 2008;269(1):85-92.
2008: Azizbek Ramankulov; Michael Lein; Manfred Johannsen; Mark Schrader; Kurt Miller; Klaus Jung
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Cancer science 2008;99(6):1188-94.
2008: Manfred Johannsen; Andreas Jordan; Peter Wust; Stefan A Loening
Re: Lyndon Gommersall, Iqbal S. Shergill, Hashim U. Ahmed et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75.
European urology 2008;53(4):860.
2007: Manfred Johannsen; Uwe Gneveckow; Burghard Thiesen; Kasra Taymoorian; Chie Hee Cho; Norbert Waldöfner; Regina Scholz; Andreas Jordan; Stefan A Loening; Peter Wust
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
European urology 2007;52(6):1653-61.
2007: Manfred Johannsen; Uwe Gneveckow; Kasra Taymoorian; Chie Hee Cho; Burghard Thiesen; Regina Scholz; Norbert Waldöfner; Stefan A Loening; Peter Wust; Andreas Jordan
[Thermal therapy of prostate cancer using magnetic nanoparticles].
Actas urologicas españolas 2007;31(6):660-7.
2007: Manfred Johannsen; Uwe Gneveckow; Kasra Taymoorian; Burghard Thiesen; Norbert Waldöfner; Regina Scholz; Klaus Jung; Andreas Jordan; Peter Wust; Stefan A Loening
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2007;23(3):315-23.
2007: Monika Jung; Azizbek Ramankulov; Jan Roigas; Manfred Johannsen; Martin Ringsdorf; Glen Kristiansen; Klaus Jung
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
BMC molecular biology 2007;8():47.
2007: Manfred Johannsen; Martin Ringsdorf; A Römer; Stefan A Loening; Jan Roigas
[Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
Aktuelle Urologie 2007;38(1):38-45.
2007: Sabine Beutner; Matthias May; Bernd Hoschke; Christian Helke; Michael Lein; Jan Roigas; Manfred Johannsen
Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive procedures.
Surgical endoscopy 2007;21(1):61-5.
2006: Peter Wust; Uwe Gneveckow; Manfred Johannsen; Dirk Böhmer; Thomas Henkel; Frank Kahmann; Jalid Sehouli; Roland Felix; Jens Ricke; Andreas Jordan
Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2006;22(8):673-85.
2006: Jan Roigas; Manfred Johannsen; Martin Ringsdorf; Gero Massenkeil
Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma.
Expert review of anticancer therapy 2006;6(10):1449-58.
2006: Venugopal Bhuvarahamurthy; Glen Kristiansen; Manfred Johannsen; Stefan A Loening; Dietmar Schnorr; Klaus Jung; Andrea Staack
In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Oncology reports 2006;15(5):1379-84.
2006: Matthias May; Manfred Johannsen; Sabine Beutner; Christian Helke; Kay-Patrick Braun; Michael Lein; Jan Roigas; Bernd Hoschke
Laparoscopic surgery versus antegrade scrotal sclerotherapy: Retrospective comparison of two different approaches for varicocele treatment.
European urology 2006;49(2):384-7.
2006: Manfred Johannsen; Burghard Thiesen; Uwe Gneveckow; Kasra Taymoorian; Norbert Waldöfner; Regina Scholz; Serdar Deger; Klaus Jung; Stefan A Loening; Andreas Jordan
Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
The Prostate 2006;66(1):97-104.
2005: Manfred Johannsen; Uwe Gneveckow; L Eckelt; Annelie Feussner; Norbert Waldöfner; Regina Scholz; Serdar Deger; Peter Wust; Stefan A Loening; Andreas Jordan
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2005;21(7):637-47.
2005: Manfred Johannsen; Stefan A Loening; Serdar Deger
Re: Current status of local salvage therapies following radiation failure for prostate cancer.
The Journal of urology 2005;174(3):1152-3; author reply 1153.
2005: Venugopal Bhuvarahamurthy; Joerg Schroeder; Glen Kristiansen; Jan Roigas; Carsten Denkert; Manfred Johannsen; Michael Lein; Stefan A Loening; Dietmar Schnorr; Klaus Jung; Andrea Staack
Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Oncology reports 2005;14(3):777-82.
2005: Manfred Johannsen; Markus Sachs; Jan Roigas; Axel Hinke; Andrea Staack; Stefan A Loening; Dietmar Schnorr; Andreas H Wille
Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer.
European urology 2005;48(2):246-51.
2005: Manfred Johannsen; Burghard Thiesen; Andreas Jordan; Kasra Taymoorian; Uwe Gneveckow; Norbert Waldöfner; Regina Scholz; Martin Koch; Michael Lein; Klaus Jung; Stefan A Loening
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
The Prostate 2005;64(3):283-92.
2004: Monika Jung; Chuanliang Xu; Jan Spethmann; Manfred Johannsen; Serdar Deger; Carsten Stephan; Stefan A Loening; Klaus Jung
Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16.
European urology 2004;46(2):271-2.
2004: Manfred Johannsen; Andreas Jordan; Regina Scholz; Martin Koch; Michael Lein; Serdar Deger; Jan Roigas; Klaus Jung; Stefan A Loening
Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer.
Journal of endourology / Endourological Society 2004;18(5):495-500.
2003: Jan Roigas; Serdar Deger; Kasra Taymoorian; Andreas H Wille; Manfred Johannsen; Ingolf Türk; Dietmar Schnorr; Stefan A Loening
Effects of 13-cis-retinoic acid on chemoimmunotherapy of metastatic renal cell carcinoma--results of a retrospective analysis.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):157-63.
2002: Michael Lein; Klaus Jung; Bernhard Ortel; Carsten Stephan; Winfried Rothaug; Rolf Juchem; Manfred Johannsen; Serdar Deger; Dietmar Schnorr; Stefan A Loening; Hans-Willi Krell
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Oncogene 2002;21(13):2089-96.